Delivery Order SPE2DP23D0001-SPE2D626F201W

The U.S. Defense Logistics Agency Medical Supply Chain division awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of February 2, 2026. The delivery will be performed at CCC's headquarters in Ottawa, Ontario, Canada. This delivery order carries no set-aside designation, consistent with CCC's status as a foreign government entity and Crown corporation owned by the Government of Canada that serves as a prime contractor facilitating government-to-government procurement relationships between U.S. defense agencies and Canadian manufacturers.

CCC has established itself as a critical supplier to the Defense Logistics Agency Medical Supply Chain, having delivered multiple specialized medical products including RSDL, Inactive Skin Decontamination Lotion, and the MOVES SLC Medical Oxygen System through numerous delivery orders. The corporation maintains three active Indefinite Delivery Contracts with the U.S. federal government valued at approximately $57.4 million collectively, with historical references indicating substantially larger defense frameworks including a $425 million Army Materiel Command ammunition contract and a $245 million Marine Corps engineering and maintenance services contract. This contract award reflects CCC's sustained strategic importance to U.S. defense logistics operations across medical supply, ammunition, aircraft components, and specialized equipment procurement.